Global Endocrine, Nutritional and Metabolic Diseases Mortality by Country

In 2023, the mortality rates for endocrine, nutritional, and metabolic diseases varied across countries, with Croatia leading at 174 deaths per hundred thousand persons, displaying significant growth at 17.27%. Estonia also marked a notable increase at 17.93%. Countries like the United States and Peru showed moderate growth at 8.04% and 8.3%, respectively. Conversely, Portugal, South Korea, and Slovakia faced declining rates, indicating slight improvements in handling these conditions. Overall, many Western European countries, such as Switzerland and the Netherlands, maintained low mortality rates, signifying more advanced healthcare interventions.

Future trends to watch include technological advancements in healthcare and tailored nutritional interventions, which are expected to curb mortality rates. Emerging public health policies targeting lifestyle diseases could drive further declines in mortality across developed nations, while under-resourced countries may require international collaborations to address their rising statistics effectively.